Admission Date:  [**2110-4-30**]              Discharge Date:   [**2110-5-14**]  Date of Birth:  [**2033-9-7**]             Sex:   F  Service: MEDICINE  Allergies: Oxaliplatin  Attending:[**First Name3 (LF) 477**] Chief Complaint: CC:[**CC Contact Info 57025**]  Major Surgical or Invasive Procedure: EGD  History of Present Illness: 76F with Stage IIB pancreatic cancer s/p whipple [**5-/2109**], DM II, aortic stenosis currently C4 Day 14 of oxaliplatin given [**2110-4-18**] and capecitabine (antimetabolite) [**Date range (1) 57026**] who felt lightheaded and dizzy yesterday morning, with some abdominal cramping.
Of note recently admitted [**4-18**] for allergic response to oxaliplatin but noted to have a decreasing hct, and coumadin for her hx of PE was held.
Received oxaliplatin [**4-18**] and was taking capecitabine from [**Date range (1) 57026**] both of which cause anemia, thrombocytopenia.
ROS: + melena, abd pain improved since ER Denies NSAIDS, ETOH   Past Medical History: Oncologic History: Stage IIB pancreatic cancer, status post Whipple surgery on [**2109-5-10**].
She then completed five weeks of external beam radiation therapy overlapping with Xeloda 500 mg twice daily as a radiosensitizer, which was completed on [**2109-9-18**].
Her dose was eventually titrated up to 1000 mg twice a day during the remaining half of her radiation treatment.
The decision was made to initiate adjuvant chemotherapy following radiation therapy for an additional two to three cycles.
In total, she completed five cycles of gemcitabine on [**2110-1-8**], complicated by the development of febrile illnesses including hypotension requiring  ICU hospitalization.
Her fifth cycle of chemotherapy was reduced to 800 mg/m2; however, two days following treatment, she required readmission to the hospital in the setting of hypotension, tachycardia.
During that evaluation, CT of the abdomen and pelvis revealed likely disease progression involving the porta hepatis in the site of her pancreatic resection.
She received her first dose on [**2110-2-13**].
Glaucoma 5. h/o uterine mixed carcinoma endometrioid and clear cell: stage Ib, grade III, s/p TAH-BSO [**9-13**] 6. history of PE at time of pancreatic cancer diagnosis, formerly on Coumadin which was stopped secondary to port hematoma.
She was treated with Coumadin for 10 months.
Family History: daughter with endometrial carcinoma, sister with liver cancer, father with lung cancer, no fam h/o blood clots  Physical Exam: HR: 78 (77 - 83) bpm BP: 127/57(75) {127/57(75) - 152/70(88)} mmHg RR: 15 (13 - 19) insp/min SpO2: 99% Height: 63 Inch T:97.3  General Appearance: No acute distress Eyes / Conjunctiva: PERRL Head, Ears, Nose, Throat: Normocephalic Cardiovascular: (S1: Normal), (S2: Normal) Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse: Present), (Right DP pulse: Present), (Left DP pulse: Present) Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : ) Abdominal: Soft, Non-tender, Bowel sounds present, Distended, + fluid wave on exam Extremities: Right: 1+, Left: 1+ Skin:  Not assessed Neurologic: Attentive, Follows simple commands, Responds to: Not assessed, Oriented (to): x3, Movement: Purposeful, Tone: Normal   Pertinent Results: EGD [**2110-5-1**]  Findings: Esophagus: Normal esophagus.
Other findings: The patient is s/p pylorus preserving whipple procedure.
The patient is s/p pylorus preserving whipple procedure.
Will initiate carafate qid while awaiting pathology results ---------------- CT [**4-30**]  CT OF THE PELVIS WITH IV CONTRAST: Multiple surgical clips are seen within the pelvis.
Patient received a total of 4 units of PRBC and 1 bag plateletes during her ICU stay.
Patient was continued on IV protonix [**Hospital1 **] and was started on caragate.
She was started intially started on Flagyl and Cefepime prior to speciation/sensitivities with the thought that she had a GI source.
On day 9 of 14 day course, she was found to have SBP and was switched from Cipro to Ceftriaxone.
She will finished Ceftriaxone on [**2110-5-18**]- which will be a complete course of antibiotics for E.coli bacteremia/UTI and SBP.
An U/S was performed showing ascites, no portal vein thrombosis.
A paracentesis was performed.
The patient was switched from Cipro to Ceftriaxone to complete a 5 day course.
Chemotherapy including capecitabine was held.
She is to have no further chemotherapy for the time being.
Medications on Admission: Atenolol 50 mg Daily  (never took) Enalapril Maleate 10 mg Daily  (never took) Glyburide 2.5mg daily, sugars<200 Lorazepam 0.5 mg Tablet Sig: [**12-11**] Q4HR PRN Cyanocobalamin 50 mcg Daily Amylase-Lipase-Protease 30,000-8,000- 30,000 unit Tablet Prochlorperazine Maleate 10 mg Q6H PRN Loperamide 2 mg Capsule QID PRN Xeloda [**Hospital1 **]   Discharge Disposition: Extended Care  Facility: [**Location (un) 583**] House  Discharge Diagnosis: Pancreatic Cancer Ulcer at Whipple site with upper gastrointestinal bleeding Ecoli Bacteremia UTI Ascites Spontaneous Bacterial Peritonitis   Discharge Condition: improved   Discharge Instructions: You were admitted for melena and were found to have a bleeding stomach ulcer.
You were also on antibiotics for this infection.
